# CK0801 for Treatment of Aplastic Anemia

> **NCT07499102** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Cellenkos, Inc.** · enrollment: 12 (estimated)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** CK0801

## Key facts

- **NCT ID:** NCT07499102
- **Lead sponsor:** Cellenkos, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-03
- **Primary completion:** 2028-08-03
- **Final completion:** 2029-08-03
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07499102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07499102, "CK0801 for Treatment of Aplastic Anemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07499102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*